Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001200212 | SCV000534169 | likely benign | not provided | 2021-01-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460950 | SCV000556577 | benign | Tuberous sclerosis 2 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200212 | SCV001371112 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
Genome- |
RCV000460950 | SCV002039215 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256237 | SCV002531088 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-21 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256237 | SCV002741661 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004000557 | SCV004821614 | benign | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing |